FBR Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform

August 10, 2015 5:42 PM

FBR Capital initiates coverage on Alnylam Pharmaceuticals (NASDAQ: ALNY) with a Outperform rating and a price target of $180.00.Analyst Christopher ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found